Lecope Tablet contains Levocetirizine 5mg, a third-generation non-sedating antihistamine used primarily for the treatment of allergic conditions. Levocetirizine is the active enantiomer of cetirizine and functions as a selective antagonist of peripheral H1 histamine receptors, effectively inhibiting the effects of histamine responsible for allergic symptoms. Lecope Tablet is indicated for the relief of symptoms associated with allergic rhinitis, including sneezing, nasal congestion, rhinorrhea, and itchy or watery eyes, as well as chronic idiopathic urticaria characterized by hives and itching. The medication demonstrates rapid onset of action and provides sustained symptom relief with once-daily dosing. Due to its high selectivity and minimal penetration of the blood-brain barrier, Levocetirizine exhibits a low incidence of sedation and central nervous system side effects compared to first-generation antihistamines. Lecope Tablet is generally well tolerated; common adverse effects may include headache, dry mouth, and fatigue. It is contraindicated in patients with known hypersensitivity to Levocetirizine or cetirizine and should be used with caution in individuals with renal impairment. Lecope Tablet offers an effective therapeutic option for managing allergic manifestations, improving patient quality of life through targeted histamine receptor blockade.